Express Scripts, CVS Face ERISA Suit Over EpiPen Costs
Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers...To view the full article, register now.
Already a subscriber? Click here to view full article